Aggressive Systemic Mastocytosis
6 clinical trials · Condition
◉ Watch Aggressive Systemic Mastocytosis
| Record | Firm | Date |
|---|---|---|
| Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM (NCT04695431) | Blueprint Medicines Corporation | 2020-12-02 |
| (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (NCT03580655) | Blueprint Medicines Corporation | 2018-11-21 |
| Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis (NCT02415608) | Jason Robert Gotlib | 2015-03-01 |
| Managed Access Programs for PKC412, Midostaurin (NCT05219266) | Novartis Pharmaceuticals |
Track Aggressive Systemic Mastocytosis automatically
Every clearance here is in the API, with alerts when new ones post.